Gloria Brosa

Gloria Brosa serves as CEO at UniPharma, S.A.. UniPharma, S.A. operates in the pharmaceuticals sector with approximately 48.0 employees. The company is headquartered in Barcelona, Catalonia. UniPharma, S.A. generates annual revenue of 11166000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 1,458 executive contacts are available in Catalonia.
• • Our database includes 201,469 c suite-level executives.

Salesforce Mobile Friendly Google Font API Apache Android

dermofarmacia cosmetica cosmeceutical skin care especialidades farmaceuticas produccion a terceros dermocosmetic pharmaceutical manufacturing dermopharmacy cosmetics medicinal products skin care solutions quality policy environmental policy pharmaceutical specialties joomla template medical clinics hospital websites sustainable products iso 9001 iso 22716 iso 14001 eu gdp compliance quality management system continuous improvement environmental impact product efficacy consumer expectations healthcare solutions data protection privacy policy user data handling healthcare websites cosmetic manufacturing web design for healthcare medical software user experience customer satisfaction medical distribution regulatory compliance professional training product innovation business strategy data security user rights cookie policy accessibility features online services digital privacy customer support scientific research market analysis professional ethics medication distribution patient care user consent pharmaceuticals medical beauty apparel & fashion ux computer & network security information technology & services

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Gloria Brosa in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at UniPharma, S.A..

Gloria Brosa's Position in the MessageCEO Database

• •Gloria Brosa is 1 of 1 verified executive contact we track at UniPharma, S.A..
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,430 verified executive contacts in Catalonia are in the database.
• •7 verified contacts work at pharmaceuticals companies in the 48.0 employee range (same size as UniPharma, S.A.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Gloria Brosa directly?

Gloria Brosa's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at UniPharma, S.A.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Gloria Brosa work for?

Gloria Brosa is CEO at UniPharma, S.A., a company in the pharmaceuticals sector with 48.0 employees. The company is based in Barcelona, Catalonia.

Can I pitch or sell to Gloria Brosa?

As CEO at UniPharma, S.A., Gloria Brosa is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Gloria Brosa directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Gloria Brosa in?

Gloria Brosa works in the pharmaceuticals industry as CEO at UniPharma, S.A.. MessageCEO provides verified contact information for executives across all major industries.

Is Gloria Brosa's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gloria Brosa's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026